News
The company's "next-generation" COVID-19 vaccine, mNexspike, was approved for adults 65 and older and younger people at risk ...
A new analysis published late last week in Vaccine concludes that COVID-19 vaccination averted 12,806 COVID-19 deaths among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback